Exclusive Report on Global Pain Management Drugs Industry: Post-COVID Growth Opportunity Analysis, Key Players | Novartis AG, Eli Lilly & Company, and Abbott Laboratories.

The global Pain Management Drugs market size is expected to reach $100.24 Billion by 2028 growing at the CAGR of 3.88% from 2021 to 2028.

With the aging population, chronic conditions such as cancer, diabetes and osteoarthritis are expected to rise. The surge in these chronic conditions lead to more people needing pain relief whether through over the counter or prescription drug use which is fueling the growth of the global pain management drugs market. Prescription drugs will lead in sales until 2028 due to their cost effectiveness and availability over the counter medications however, non-prescription drugs available for consumer purchase will begin to lose its marketing share and reduce slightly.

Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=005563

Key Players

Some of the major Pain Management Drugs players holding high market share include Novartis AG, Eli Lilly & Company, and Abbott Laboratories. These players use acquisition and collaboration as a key strategy to gain significant market share to compete with market leaders.

The key players profiled in the report are:
● Novartis AG
● Eli Lilly & Company
● Abbott Laboratories
● Endo Health Solutions, Inc
● Purdue Pharma L.P
● Pfizer, Inc.
● Mylan NV.
● Merck & Co. Inc
● Johnson & Johnson
● GlaxoSmithKline Plc

The recently published research report on Global Pain Management Drugs Market by Evolve Business Intelligence examines the industry in the context of major market aspects including market size & forecast, market shares in terms of revenues and volume, key players, and SWOT analysis. The market is analyzed based on 4 separate indications in the market dynamic chapter: Drivers, Restraints, Key Trends, and Challenges. The total sum of these sections will help you understand what strategies will be best to adopt in order to prosper through this industry over a few short years. The quantitative analysis includes our actual findings out of this research study where we provided additional insight into what our readers can do to embrace new opportunities or plan against threats that might hinder the market.

The COVID-19 pandemic has led to disruption in the supply chain leading to lower demand or supply shortages in the Pain Management Drugs market. The travel restrictions and social-distancing measures have resulted in a sharp drop in consumer and business spending and this pattern is expected to continue for some time. The end-user trend and preferences have changed due to the pandemic and have resulted in manufacturers, developers, and service providers adopting various strategies to stabilize the company.

The New Normal

As businesses recover from the COVID-19 pandemic, they have a new set of priorities to cope with. Throughout this crisis, they were forced to deal with shifting situations and often fell short of their ultimate goals. Now that a cure has been found and the pandemic is dying down, they will need to recuperate from this epidemic by setting forth new objectives to succeed in the future.

In terms of COVID 19 impact, the Pain Management Drugs market report also includes the following data points:
● COVID19 Impact on Pain Management Drugs market size
● End-User/Industry/Application Trend, and Preferences
● Government Policies/Regulatory Framework
● Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
● Opportunity in Pain Management Drugs market

Segmental Analysis

Market Segment By Drug Class with focus on market share, consumption trend, and growth rate of Pain Management Drugs Market:
o NSAIDs
o Anesthetics
o Anticonvulsants
o Others

Market Segment By Indication with the focus on market share, consumption trend, and growth rate of Pain Management Drugs Market:
o Arthritic Pain
o Neuropathic Pain
o Others

For more information: https://evolvebi.com/product/pain-management-drugs-market-analysis-and-forecast-2021-2028-with-covid-impact-analysis/

Key Region/ Countries Covered
● North America (US, Canada, Mexico)
● Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
● Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
● Rest of the World (the Middle East & Africa and South America)

The North American pain management drugs market is expected to remain dominant throughout the forecast period owing to factors such as large number of aging population, increase in healthcare expenditure, and favorable government regulations.

The Asia Pacific pain management drugs market is estimated to witness fastest growth in terms of revenue during the forecast period, owing to increasing prevalence of painful conditions in the region and significant rise in healthcare spending.

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging the pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.

This release was published on openPR.